Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Health Promot Chronic Dis Prev Can ; 36(7): 130-8, 2016 Jul.
Artigo em Inglês, Francês | MEDLINE | ID: mdl-27409988

RESUMO

INTRODUCTION: Although e-cigarette use ("vaping") is increasing in Canada, few attempts have been made to describe e-cigarette users ("vapers"). In this context, we conducted a study in Ottawa, Canada, to describe e-cigarette users' perceptions of the benefits, harms and risks of e-cigarettes. We also collected information on why, how and where they use e-cigarettes as well as information on side effects. METHODS: A 24-item online survey was administered to individuals who purchased e-cigarettes or e-cigarette-related supplies at one of Ottawa's 17 e-cigarette shops. Descriptive analyses characterized respondents, and logistic regression models were fitted to evaluate the relationship between respondents' characteristics and their perception of e-cigarette harms. RESULTS: The mean age of the 242 respondents was 38.1 years (range: 16-70 years); 66% were male. Nearly all had smoked 100 or more cigarettes in their lifetime (97.9%). More than 80% indicated that quitting smoking was a very important reason for starting to use e-cigarettes and 60% indicated that they intend to stop using e-cigarettes at some point. About 40% reported experiencing some side effects within 2 hours of using e-cigarettes. Those who did not report experiencing any of the listed side effects had approximately 3.2 times higher odds of perceiving e-cigarettes as harmless than those who reported having side effects (odds ratio = 3.17; 95% confidence interval: 1.75-5.73). CONCLUSION: Our findings suggest that most e-cigarette users are using them to reduce or stop smoking cigarettes and perceive them as harmless. Due to our use of convenience sampling, the reader should be cautious in generalizing our findings to all Canadian e-cigarette users.


INTRODUCTION: Bien que l'utilisation de la cigarette électronique (« vapotage ¼) soit en hausse au Canada, peu d'efforts ont été consacrés à la description des utilisateurs de cigarettes électroniques (« vapoteurs ¼). C'est dans ce contexte que nous avons mené une étude à Ottawa (Canada) afin de décrire les perceptions qu'ont les utilisateurs de cigarettes électroniques des avantages, des dangers et des risques de ces dernières. Nous avons également recueilli de l'information pour savoir pourquoi, comment et où ils utilisent la cigarette électronique ainsi que sur les effets secondaires. MÉTHODOLOGIE: Un sondage en ligne de 24 questions a été soumis à des personnes ayant acheté des cigarettes électroniques ou des fournitures connexes dans l'un des 17 commerces de cigarettes électroniques à Ottawa. On a caractérisé les répondants au moyen d'analyses descriptives, puis nous avons appliqué des modèles de régression logistique pour évaluer la relation entre ces caractéristiques et la perception par les répondants des dangers de la cigarette électronique. RÉSULTATS: L'âge moyen des 242 répondants était de 38,1 ans (plage : 16 à 70 ans) et, de ce nombre, 66 % étaient des hommes. Près de la totalité (97,9 %) des répondants avaient fumé 100 cigarettes ou plus au cours de leur vie. Plus de 80 % des répondants ont indiqué que la volonté d'arrêter de fumer constituait l'une des principales raisons de recourir à la cigarette électronique, et 60 % ont mentionné qu'ils avaient l'intention de cesser l'utilisation de la cigarette électronique un jour. Environ 40 % des répondants ont fait état d'effets secondaires au cours des 2 heures suivant l'utilisation des cigarettes électroniques. Les répondants ayant signalé n'avoir ressenti aucun des effets secondaires énumérés étaient environ 3,2 fois plus nombreux à ne percevoir aucun danger dans la cigarette électronique que les personnes ayant signalé des effets secondaires (rapport de cotes = 3,17; intervalle de confiance à 95 % : 1,75 à 5,73). CONCLUSION: D'après nos constatations, la majorité des utilisateurs de cigarettes électroniques ont recours à ces dernières pour réduire ou cesser leur consommation de tabac et ils les perçoivent comme inoffensives. Étant donné que nous avons utilisé un échantillonnage de commodité, le lecteur doit faire preuve de prudence dans la généralisation de nos constatations à tous les utilisateurs de cigarettes électroniques au Canada.


Assuntos
Sistemas Eletrônicos de Liberação de Nicotina , Adolescente , Adulto , Idoso , Canadá/epidemiologia , Sistemas Eletrônicos de Liberação de Nicotina/efeitos adversos , Sistemas Eletrônicos de Liberação de Nicotina/psicologia , Sistemas Eletrônicos de Liberação de Nicotina/estatística & dados numéricos , Feminino , Inquéritos Epidemiológicos , Humanos , Masculino , Medição de Risco , Fumar/epidemiologia , Fumar/psicologia , Abandono do Hábito de Fumar/métodos , Abandono do Hábito de Fumar/psicologia , Percepção Social
2.
Lancet ; 357(9263): 1161-7, 2001 Apr 14.
Artigo em Inglês | MEDLINE | ID: mdl-11323043

RESUMO

BACKGROUND: Data on the epidemiology of reproductive-organ morbidity are needed to guide effective interventions, to set health-care priorities, and to target future research. This study aimed to find out the prevalence of reproductive-organ disease in a sample of rural Gambian women. METHODS: A questionnaire on reproductive health was administered by fieldworkers to women aged 15-54 years living in a rural area under demographic surveillance. A female gynaecologist questioned and examined the women (including speculum and bimanual pelvic examinations). Vaginal swabs were taken to test for Trichomonas vaginalis, Candida albicans, and bacterial vaginosis, cervical smears for cytology, cervical swabs for Chlamydia trachomatis PCR and Neisseria gonorrhoeae culture, and venous blood for haemoglobin, HIV, herpes simplex virus 2, and syphilis serology. FINDINGS: 1348 (72.0%) of 1871 eligible women took part. Reproductive-organ symptoms were more likely to be reported to the gynaecologist (52.7% of women) than to the fieldworker (26.5%). Menstrual problems, abnormal vaginal discharge, and vaginal itching were the most commonly reported symptoms. A minority of women said they had sought health care for their symptoms. The frequencies of reproductive-organ morbidity were high: menstrual dysfunction 34.1% (95% CI 29.6-39.1), infertility 9.8% (8.2-11.6), reproductive-tract infections 47.3% (43.7-51.0), pelvic tenderness 9.8% ((7.0-13.5), cervical dysplasia 6.7% (5.2-8.4), masses 15.9% (12.5-20.1), and childbirth-related damage to pelvic structures 46.1% (40.1-52.3). 948 (70.3%) women had at least one reproductive-organ disorder. INTERPRETATION: For these rural women, whose lives depend heavily on their reproductive function, reproductive-organ disease is a large burden. In inadequately resourced rural areas, with poor education, heavy agricultural and domestic labour, and limited access to quality health care, many women are not able to attain and maintain reproductive health and wellbeing.


Assuntos
Efeitos Psicossociais da Doença , Países em Desenvolvimento , Doenças dos Genitais Femininos/epidemiologia , Saúde da População Rural , Saúde da Mulher , Adolescente , Adulto , Feminino , Gâmbia/epidemiologia , Doenças dos Genitais Femininos/diagnóstico , Doenças dos Genitais Femininos/etnologia , Humanos , Pessoa de Meia-Idade , Morbidade , Aceitação pelo Paciente de Cuidados de Saúde , Prevalência , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA